News

Learn how and where to inject Zepbound and where to get additional help. Plus, get tips for injecting the drug at home and ...
Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...
Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...
Patients regularly taking Eli Lilly & Co.’s obesity shot Zepbound tend to keep the weight off for at least three years, with ...
A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...
Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...
Ryan Rasmussen was determined to lose weight so he would be around to ski and spend time with his wife and children.
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...
After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
Let's look at why this news could be a game-changer for Eli Lilly and its stock.